9/17
06:04 am
ymab
Form EFFECT Y-mAbs Therapeutics,
Neutral
Report
Form EFFECT Y-mAbs Therapeutics,
9/16
09:10 am
ymab
Form S-8 POS Y-mAbs Therapeutics,
Neutral
Report
Form S-8 POS Y-mAbs Therapeutics,
9/16
09:08 am
ymab
Form S-8 POS Y-mAbs Therapeutics,
Neutral
Report
Form S-8 POS Y-mAbs Therapeutics,
9/16
09:07 am
ymab
Form S-8 POS Y-mAbs Therapeutics,
Neutral
Report
Form S-8 POS Y-mAbs Therapeutics,
9/16
09:05 am
ymab
Form S-8 POS Y-mAbs Therapeutics,
Neutral
Report
Form S-8 POS Y-mAbs Therapeutics,
9/16
09:04 am
ymab
Form POS AM Y-mAbs Therapeutics,
Neutral
Report
Form POS AM Y-mAbs Therapeutics,
9/16
08:59 am
ymab
Form 8-K Y-mAbs Therapeutics, For: Sep 16
Neutral
Report
Form 8-K Y-mAbs Therapeutics, For: Sep 16
9/16
08:56 am
ymab
Form SC 14D9/A Y-mAbs Therapeutics, Filed by: Y-mAbs Therapeutics, Inc.
Neutral
Report
Form SC 14D9/A Y-mAbs Therapeutics, Filed by: Y-mAbs Therapeutics, Inc.
9/16
08:56 am
ymab
Form 25-NSE Y-mAbs Therapeutics, Filed by: Nasdaq Stock Market LLC
Neutral
Report
Form 25-NSE Y-mAbs Therapeutics, Filed by: Nasdaq Stock Market LLC
9/16
08:50 am
ymab
Form SC TO-T/A Y-mAbs Therapeutics, Filed by: Perseus BidCo US, Inc.
Neutral
Report
Form SC TO-T/A Y-mAbs Therapeutics, Filed by: Perseus BidCo US, Inc.